scholarly journals Generation of Cytotoxic T Cells Against Virus-Infected Human Brain Macrophages in a Murine Model of HIV-1 Encephalitis

2002 ◽  
Vol 168 (10) ◽  
pp. 5376.2-5376
Author(s):  
Larisa Y. Poluektova ◽  
David H. Munn ◽  
Yuri Persidsky ◽  
Howard E. Gendelman
2002 ◽  
Vol 168 (8) ◽  
pp. 3941-3949 ◽  
Author(s):  
Larisa Y. Poluektova ◽  
David H. Munn ◽  
Yuri Persidsky ◽  
Howard E. Gendelman

2016 ◽  
Vol 90 (16) ◽  
pp. 7066-7083 ◽  
Author(s):  
Saikrishna Gadhamsetty ◽  
Tim Coorens ◽  
Rob J. de Boer

ABSTRACTSeveral experiments suggest that in the chronic phase of human immunodeficiency virus type 1 (HIV-1) infection, CD8+cytotoxic T lymphocytes (CTL) contribute very little to the death of productively infected cells. First, the expected life span of productively infected cells is fairly long, i.e., about 1 day. Second, this life span is hardly affected by the depletion of CD8+T cells. Third, the rate at which mutants escaping a CTL response take over the viral population tends to be slow. Our main result is that all these observations are perfectly compatible with killing rates that are much faster than one per day once we invoke the fact that infected cells proceed through an eclipse phase of about 1 day before they start producing virus. Assuming that the major protective effect of CTL is cytolytic, we demonstrate that mathematical models with an eclipse phase account for the data when the killing is fast and when it varies over the life cycle of infected cells. Considering the steady state corresponding to the chronic phase of the infection, we find that the rate of immune escape and the rate at which the viral load increases following CD8+T cell depletion should reflect the viral replication rate, ρ. A meta-analysis of previous data shows that viral replication rates during chronic infection vary between 0.5 ≤ ρ ≤ 1 day−1. Balancing such fast viral replication requires killing rates that are several times larger than ρ, implying that most productively infected cells would die by cytolytic effects.IMPORTANCEMost current data suggest that cytotoxic T cells (CTL) mediate their control of human immunodeficiency virus type 1 (HIV-1) infection by nonlytic mechanisms; i.e., the data suggest that CTL hardly kill. This interpretation of these data has been based upon the general mathematical model for HIV infection. Because this model ignores the eclipse phase between the infection of a target cell and the start of viral production by that cell, we reanalyze the same data sets with novel models that do account for the eclipse phase. We find that the data are perfectly consistent with lytic control by CTL and predict that most productively infected cells are killed by CTL. Because the killing rate should balance the viral replication rate, we estimate both parameters from a large set of published experiments in which CD8+T cells were depleted in simian immunodeficiency virus (SIV)-infected monkeys. This confirms that the killing rate can be much faster than is currently appreciated.


2010 ◽  
Vol 71 (2) ◽  
pp. 123-127 ◽  
Author(s):  
Masao Hashimoto ◽  
Mitsutaka Kitano ◽  
Kazutaka Honda ◽  
Hirokazu Koizumi ◽  
Sachi Dohki ◽  
...  

AIDS ◽  
1999 ◽  
Vol 13 (12) ◽  
pp. 1583 ◽  
Author(s):  
Rosângela Salerno-Gonçalves ◽  
Wei Lu ◽  
Ammar Achour ◽  
Jean-Marie Andrieu

2015 ◽  
Vol 89 (10) ◽  
pp. 5330-5339 ◽  
Author(s):  
Hayato Murakoshi ◽  
Tomohiro Akahoshi ◽  
Madoka Koyanagi ◽  
Takayuki Chikata ◽  
Takuya Naruto ◽  
...  

ABSTRACTIdentification and characterization of CD8+T cells effectively controlling HIV-1 variants are necessary for the development of AIDS vaccines and for studies of AIDS pathogenesis, although such CD8+T cells have been only partially identified. In this study, we sought to identify CD8+T cells controlling HIV-1 variants in 401 Japanese individuals chronically infected with HIV-1 subtype B, in which protective alleles HLA-B*57 and HLA-B*27 are very rare, by using comprehensive and exhaustive methods. We identified 13 epitope-specific CD8+T cells controlling HIV-1 in Japanese individuals, though 9 of these epitopes were not previously reported. The breadths of the T cell responses to the 13 epitopes were inversely associated with plasma viral load (P= 2.2 × 10−11) and positively associated with CD4 count (P= 1.2 × 10−11), indicating strong synergistic effects of these T cells on HIV-1 controlin vivo. Nine of these epitopes were conserved among HIV-1 subtype B-infected individuals, whereas three out of four nonconserved epitopes were cross-recognized by the specific T cells. These findings indicate that these 12 epitopes are strong candidates for antigens for an AIDS vaccine. The present study highlighted a strategy to identify CD8+T cells controlling HIV-1 and demonstrated effective control of HIV-1 by those specific for 12 conserved or cross-reactive epitopes.IMPORTANCEHLA-B*27-restricted and HLA-B*57-restricted cytotoxic T lymphocytes (CTLs) play a key role in controlling HIV-1 in Caucasians and Africans, whereas it is unclear which CTLs control HIV-1 in Asian countries, where HLA-B*57 and HLA-B*27 are very rare. A recent study showed that HLA-B*67:01 and HLA-B*52:01-C*12:02 haplotypes were protective alleles in Japanese individuals, but it is unknown whether CTLs restricted by these alleles control HIV-1. In this study, we identified 13 CTLs controlling HIV-1 in Japan by using comprehensive and exhaustive methods. They included 5 HLA-B*52:01-restricted and 3 HLA-B*67:01-restricted CTLs, suggesting that these CTLs play a predominant role in HIV-1 control. The 13 CTLs showed synergistic effects on HIV-1 control. Twelve out of these 13 epitopes were recognized as conserved or cross-recognized ones. These findings strongly suggest that these 12 epitopes are candidates for antigens for AIDS vaccines.


2016 ◽  
Vol 04 (04) ◽  
pp. 191-212
Author(s):  
Chipo Mufudza ◽  
Senelani D. Hove-Musekwa ◽  
Edward T. Chiyaka

2011 ◽  
Vol 230 (1-2) ◽  
pp. 33-41 ◽  
Author(s):  
Nan Gong ◽  
Jianuo Liu ◽  
Ashley D. Reynolds ◽  
Santhi Gorantla ◽  
R. Lee Mosley ◽  
...  

Blood ◽  
2014 ◽  
Vol 124 (16) ◽  
pp. 2514-2522 ◽  
Author(s):  
Ida Ricciardelli ◽  
Michael Patrick Blundell ◽  
Jennifer Brewin ◽  
Adrian Thrasher ◽  
Martin Pule ◽  
...  

Key Points EBV-CTLs resistant to calcineurin inhibitors mediate durable, potent antitumor responses despite immunosuppression in a murine model of PTLD. This approach improves immunotherapy efficacy with EBV-CTLs for PTLD after SOT and obviates need for immunosuppression withdrawal.


Sign in / Sign up

Export Citation Format

Share Document